What is Biogen's revenue?

Biogen (BIIB) generated $9.9B in revenue over the trailing twelve months, up 1.2% year over year.

Is Biogen profitable?

Biogen reported $1.4B in net income over the trailing twelve months, a 14.3% net margin.

What are Biogen's profit margins?

Gross margin is 75.5% and operating margin is 22.9%, with a 14.3% net margin.

What is Biogen's earnings per share?

Biogen's diluted EPS over the trailing twelve months is $9.65.

Where does Biogen's income statement data come from?

Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Biogen BIIB Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$9.94B+1.2%	$9.89B+2.2%	$10.07B+4.8%	$10B+3.4%	$9.82B+1.6%
Total cost of revenue	$2.44B+1.6%	$2.4B+4.1%	$2.49B+6.3%	$2.46B+3.8%	$2.4B-0.6%
Gross profit	$7.5B+1.1%	$7.49B+1.6%	$7.57B+4.3%	$7.54B+3.2%	$7.42B+2.3%
Gross margin	75.5%-0.1pp	75.7%-0.4pp	75.2%-0.3pp	75.4%-0.1pp	75.6%+0.5pp
Research and development	$1.88B-4.3%	$1.78B-10.2%	$1.78B-11.8%	$1.86B-16.9%	$1.97B-15.1%
Selling, general and administrative	$2.47B+3.1%	$2.43B+1.2%	$2.43B+4.2%	$2.42B-4.2%	$2.39B-5.2%
Total costs & expenses	$8.31B+3.1%	$8.33B+7.3%	$8.16B+6.0%	$8.2B-1.9%	$8.06B-3.3%
Interest expense	——	——	——	——	——
Other income (expense), net	-$306.2M+9.7%	-$302.6M+11.9%	-$323.9M-2.8%	-$340.5M-7.2%	-$339.2M-6.7%
Income before income taxes	$1.68B-4.2%	$1.61B-15.4%	$1.9B-0.1%	$1.8B+36.8%	$1.75B+32.4%
Income tax expense	$258.2M-5.5%	$270.7M-1.1%	$295.5M+1.3%	$267.2M+71.0%	$273.1M+75.1%
Net income	$1.42B-4.0%	$1.34B-17.8%	$1.61B-0.4%	$1.53B+32.1%	$1.48B+26.8%
Net margin	14.3%-0.8pp	13.6%-3.3pp	16%-0.8pp	15.3%+3.3pp	15.1%+3.0pp
Diluted earnings per share	$9.65-4.7%	$9.14-18.3%	$10.97-0.9%	$10.46+31.7%	$10.13+26.5%
EBITDA	$2.69B+1.7%	$2.59B-6.4%	$2.87B+5.2%	$2.73B+31.5%	$2.64B+29.8%
EBITDA margin	27%+0.1pp	26.2%-2.4pp	28.5%+0.1pp	27.4%+5.8pp	26.9%+5.9pp
EBIT	$1.89B-2.4%	$1.81B-13.5%	$2.1B+0.4%	$1.99B+32.0%	$1.93B+28.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Biogen.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biogen's revenue?: Biogen (BIIB) generated $9.9B in revenue over the trailing twelve months, up 1.2% year over year.
Is Biogen profitable?: Biogen reported $1.4B in net income over the trailing twelve months, a 14.3% net margin.
What are Biogen's profit margins?: Gross margin is 75.5% and operating margin is 22.9%, with a 14.3% net margin.
What is Biogen's earnings per share?: Biogen's diluted EPS over the trailing twelve months is $9.65.
Where does Biogen's income statement data come from?: Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.